The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer

por Dobbin, Zachary C., Landen, Charles N.
Publicado 2013

Metastatic papillary serous uterine cancer presenting as a rash

por Chang, Eric S., Baker, William D., Landen, Charles N.
Publicado 2016

Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review

por Cornelison, Robert, Llaneza, Danielle C., Landen, Charles N.
Publicado 2017

A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer

por Perez, Samantha M., Dimastromatteo, Julien, Landen, Charles N., Kelly, Kimberly A.
Publicado 2021

Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane

por Chen, Huaping, Landen, Charles N., Li, Yuanyuan, Alvarez, Ronald D., Tollefsbol, Trygve O.
Publicado 2013

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer

por Emmings, Edith, Mullany, Sally, Chang, Zenas, Landen, Charles N., Linder, Stig, Bazzaro, Martina
Publicado 2019

ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells

por Schultz, Matthew J, Swindall, Amanda F, Wright, John W, Sztul, Elizabeth S, Landen, Charles N, Bellis, Susan L
Publicado 2013

CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer

por Cornelison, Robert, Biswas, Kuntal, Llaneza, Danielle C., Harris, Alexandra R., Sosale, Nisha G., Lazzara, Matthew J., Landen, Charles N.
Publicado 2021

Proteasome inhibition reverses hedgehog inhibitor and taxane resistance in ovarian cancer

por Steg, Adam D., Burke, Mata R., Amm, Hope M., Katre, Ashwini A., Dobbin, Zachary C., Jeong, Dae Hoon, Landen, Charles N.
Publicado 2014

A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors

por Shivange, Gururaj, Mondal, Tanmoy, Lyerly, Evan, Bhatnagar, Sanchita, Landen, Charles N., Reddy, Shivani, Kim, Jonathan, Doan, Britney, Riddle, Paula, Tushir-Singh, Jogender
Publicado 2021

Credentialing and Pharmacologically Targeting PTP4A3 Phosphatase as a Molecular Target for Ovarian Cancer

por Lazo, John S., Sharlow, Elizabeth R., Cornelison, Robert, Hart, Duncan J., Llaneza, Danielle C., Mendelson, Anna J., Rastelli, Ettore J., Tasker, Nikhil R., Landen, Charles N., Wipf, Peter
Publicado 2021

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer

por Dobbin, Zachary C., Katre, Ashwini A., Steg, Adam D., Erickson, Britt K., Shah, Monjri M., Alvarez, Ronald D., Conner, Michael G., Schneider, David, Chen, Dongquan, Landen, Charles N.
Publicado 2014

Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer

por Arend, Rebecca C., Londoño-Joshi, Angelina I., Gangrade, Abhishek, Katre, Ashwini A., Kurpad, Chandrika, Li, Yonghe, Samant, Rajeev S., Li, Pui-Kai, Landen, Charles N., Yang, Eddy S., Hidalgo, Bertha, Alvarez, Ronald D., Michael Straughn, John, Forero, Andres, Buchsbaum, Donald J.
Publicado 2016

Correction: Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer

por Arend, Rebecca C., Londoño-Joshi, Angelina I., Gangrade, Abhishek, Katre, Ashwini A., Kurpad, Chandrika, Li, Yonghe, Samant, Rajeev S., Li, Pui-Kai, Landen, Charles N., Yang, Eddy S., Hidalgo, Bertha, Alvarez, Ronald D., Straughn, John Michael, Forero, Andres, Buchsbaum, Donald J.
Publicado 2018

Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor

por McQueeney, Kelley E., Salamoun, Joseph M., Burnett, James C., Barabutis, Nektarios, Pekic, Paula, Lewandowski, Sophie L., Llaneza, Danielle C., Cornelison, Robert, Bai, Yunpeng, Zhang, Zhong-Yin, Catravas, John D., Landen, Charles N., Wipf, Peter, Lazo, John S., Sharlow, Elizabeth R.
Publicado 2017

Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial

por Landen, Charles N., Molinero, Luciana, Hamidi, Habib, Sehouli, Jalid, Miller, Austin, Moore, Kathleen N., Taskiran, Cagatay, Bookman, Michael, Lindemann, Kristina, Anderson, Charles, Berger, Regina, Myers, Tashanna, Beiner, Mario, Reid, Thomas, Van Nieuwenhuysen, Els, Green, Andrew, Okamoto, Aikou, Aghajanian, Carol, Thaker, Premal H., Blank, Stephanie V., Khor, Victor K., Chang, Ching-Wei, Lin, Yvonne G., Pignata, Sandro
Publicado 2023

Platinum Chemotherapy Induces Lymphangiogenesis in Cancerous and Healthy Tissues That Can be Prevented With Adjuvant Anti-VEGFR3 Therapy

por Harris, Alexandra R., Esparza, Savieay, Azimi, Mohammad S., Cornelison, Robert, Azar, Francesca N., Llaneza, Danielle C., Belanger, Maura, Mathew, Alexander, Tkachenko, Svyatoslav, Perez, Matthew J., Rosean, Claire Buchta, Bostic, Raegan R., Cornelison, R. Chase, Tate, Kinsley M., Peirce-Cottler, Shayn M., Paquette, Cherie, Mills, Anne, Landen, Charles N., Saucerman, Jeff, Dillon, Patrick M., Pompano, Rebecca R., Rutkowski, Melanie A., Munson, Jennifer M.
Publicado 2022